Literature DB >> 22752412

Epidemiology of henipavirus disease in humans.

Stephen P Luby1, Emily S Gurley.   

Abstract

All seven recognized human cases of Hendra virus (HeV) infection have occurred in Queensland, Australia. Recognized human infections have all resulted from a HeV infected horse that was unusually efficient in transmitting the virus and a person with a high exposure to infectious secretions. In the large outbreak in Malaysia where Nipah virus (NiV) was first identified, most human infections resulted from close contact with NiV infected pigs. Outbreak investigations in Bangladesh have identified drinking raw date palm sap as the most common pathway of NiV transmission from Pteropus bats to people, but person-to-person transmission of NiV has been repeatedly identified in Bangladesh and India. Although henipaviruses are not easily transmitted to people, these newly recognized, high mortality agents warrant continued scientific attention.

Entities:  

Mesh:

Year:  2012        PMID: 22752412     DOI: 10.1007/82_2012_207

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  30 in total

1.  Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.

Authors:  Tatyana Yun; Arnold Park; Terence E Hill; Olivier Pernet; Shannon M Beaty; Terry L Juelich; Jennifer K Smith; Lihong Zhang; Yao E Wang; Frederic Vigant; Junling Gao; Ping Wu; Benhur Lee; Alexander N Freiberg
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Piloting the promotion of bamboo skirt barriers to prevent Nipah virus transmission through date palm sap in Bangladesh.

Authors:  Nazmun Nahar; Utpal Kumar Mondal; M Jahangir Hossain; M Salah Uddin Khan; Rebeca Sultana; Emily S Gurley; Stephen P Luby
Journal:  Glob Health Promot       Date:  2014-04-22

3.  Investigating Rare Risk Factors for Nipah Virus in Bangladesh: 2001-2012.

Authors:  Sonia T Hegde; Hossain M S Sazzad; M Jahangir Hossain; Mahbub-Ul Alam; Eben Kenah; Peter Daszak; Pierre Rollin; Mahmudur Rahman; Stephen P Luby; Emily S Gurley
Journal:  Ecohealth       Date:  2016-10-13       Impact factor: 3.184

4.  Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.

Authors:  Blair L DeBuysscher; Dana Scott; Andrea Marzi; Joseph Prescott; Heinz Feldmann
Journal:  Vaccine       Date:  2014-03-12       Impact factor: 3.641

5.  Functional rectification of the newly described African henipavirus fusion glycoprotein (Gh-M74a).

Authors:  Olivier Pernet; Shannon Beaty; Benhur Lee
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

6.  Using healthcare-seeking behaviour to estimate the number of Nipah outbreaks missed by hospital-based surveillance in Bangladesh.

Authors:  Sonia T Hegde; Henrik Salje; Hossain M S Sazzad; M Jahangir Hossain; Mahmudur Rahman; Peter Daszak; John D Klena; Stuart T Nichol; Stephen P Luby; Emily S Gurley
Journal:  Int J Epidemiol       Date:  2019-08-01       Impact factor: 7.196

Review 7.  A treatment for and vaccine against the deadly Hendra and Nipah viruses.

Authors:  Christopher C Broder; Kai Xu; Dimitar B Nikolov; Zhongyu Zhu; Dimiter S Dimitrov; Deborah Middleton; Jackie Pallister; Thomas W Geisbert; Katharine N Bossart; Lin-Fa Wang
Journal:  Antiviral Res       Date:  2013-07-06       Impact factor: 5.970

8.  Hendra virus and Nipah virus animal vaccines.

Authors:  Christopher C Broder; Dawn L Weir; Peter A Reid
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

9.  Nipah virus attachment glycoprotein stalk C-terminal region links receptor binding to fusion triggering.

Authors:  Qian Liu; Birgit Bradel-Tretheway; Abrrey I Monreal; Jonel P Saludes; Xiaonan Lu; Anthony V Nicola; Hector C Aguilar
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

10.  Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.

Authors:  Thomas W Geisbert; Chad E Mire; Joan B Geisbert; Yee-Peng Chan; Krystle N Agans; Friederike Feldmann; Karla A Fenton; Zhongyu Zhu; Dimiter S Dimitrov; Dana P Scott; Katharine N Bossart; Heinz Feldmann; Christopher C Broder
Journal:  Sci Transl Med       Date:  2014-06-25       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.